Clinical Trial Update: Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects With Epicutanoeus Allergen Administration [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of grass pollen allergen immunotherapy delivered via epicutaneous administration in subjects with alle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinoconjunctivitis

Drugs mentioned

• Grass pollen allergen immunotherapy (epicutaneous administration)

Snippet

Sponsor: University of Zurich | Conditions: Allergic Rhinoconjunctivitis | Phase 2 | Status: COMPLETED